Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Flagellin concentrations in expectorations from cystic fibrosis patients

Authors: Viviane Balloy, Guiti Thévenot, Thierry Bienvenu, Philippe Morand, Harriet Corvol, Annick Clement, Reuben Ramphal, Dominique Hubert, Michel Chignard

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

The aim was to measure flagellin concentrations in the expectorations of CF patients and to examine whether there are correlations with the level of respiratory insufficiency and inflammation.

Methods

Sputum samples from 31 adult patients chronically colonized with P. aeruginosa were collected and analysed for their content of flagellin and IL-8. Clinical data were extracted from patient files.

Results

Regardless of whether patients are colonized with mucoid strains or not, they carry clones of P. aeruginosa that express flagellin. While flagellin was present in airways of all of our CF patients, it is difficult to ascertain its contribution to inflammation (IL-8) and lung function deterioration.

Conclusions

This is the first demonstration that flagellin is present in the sputum of patients. Thus, attempts to down regulate inflammation by the use of TLR5 (flagellin receptor) antagonists remain a possibility. However, this result needs to be extended to a larger number of patients to validate it for future research on this subject.
Appendix
Available only for authorised users
Literature
1.
go back to reference Callaghan M, McClean S: Bacterial host interactions in cystic fibrosis. Curr Opin Microbiol. 2012, 15: 71-77. 10.1016/j.mib.2011.11.001.CrossRefPubMed Callaghan M, McClean S: Bacterial host interactions in cystic fibrosis. Curr Opin Microbiol. 2012, 15: 71-77. 10.1016/j.mib.2011.11.001.CrossRefPubMed
4.
go back to reference Stenbit AE, Flume PA: Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2011, 17: 442-447.PubMed Stenbit AE, Flume PA: Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2011, 17: 442-447.PubMed
5.
go back to reference Chotirmall SH, Smith SG, Gunaratnam C, Cosgrove S, Dimitrov BD, O’Neill SJ, Harvey BJ, Greene CM, McElvaney NG: Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med. 2012, 366: 1978-1986. 10.1056/NEJMoa1106126.CrossRefPubMed Chotirmall SH, Smith SG, Gunaratnam C, Cosgrove S, Dimitrov BD, O’Neill SJ, Harvey BJ, Greene CM, McElvaney NG: Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med. 2012, 366: 1978-1986. 10.1056/NEJMoa1106126.CrossRefPubMed
6.
go back to reference Waters V, Ratjen F: Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev. 2008, 3: CD006961-PubMed Waters V, Ratjen F: Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev. 2008, 3: CD006961-PubMed
7.
go back to reference Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, Tümmler B, Vavrova V, De Boeck K: Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011, 10 (2): S79-S81.CrossRefPubMed Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, Tümmler B, Vavrova V, De Boeck K: Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011, 10 (2): S79-S81.CrossRefPubMed
8.
go back to reference Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, Galán JE, Flavell RA, Alexopoulou L: Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A. 2006, 103: 12487-12492. 10.1073/pnas.0605200103.CrossRefPubMedPubMedCentral Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, Galán JE, Flavell RA, Alexopoulou L: Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A. 2006, 103: 12487-12492. 10.1073/pnas.0605200103.CrossRefPubMedPubMedCentral
9.
go back to reference Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM: Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol. 2007, 292: L312-L322.CrossRefPubMed Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM: Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol. 2007, 292: L312-L322.CrossRefPubMed
10.
go back to reference Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, Chignard M: Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol. 2008, 181: 586-592. 10.4049/jimmunol.181.1.586.CrossRefPubMedPubMedCentral Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, Chignard M: Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol. 2008, 181: 586-592. 10.4049/jimmunol.181.1.586.CrossRefPubMedPubMedCentral
11.
go back to reference Adamo R, Sokol S, Soong G, Gomez MI, Prince A: Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol. 2004, 30: 627-634. 10.1165/rcmb.2003-0260OC.CrossRefPubMed Adamo R, Sokol S, Soong G, Gomez MI, Prince A: Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol. 2004, 30: 627-634. 10.1165/rcmb.2003-0260OC.CrossRefPubMed
12.
go back to reference Oshikawa K, Sugiyama AL: Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun. 2003, 305: 649-655. 10.1016/S0006-291X(03)00837-4.CrossRefPubMed Oshikawa K, Sugiyama AL: Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun. 2003, 305: 649-655. 10.1016/S0006-291X(03)00837-4.CrossRefPubMed
13.
go back to reference Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M: Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem. 2004, 279: 2712-2718.CrossRefPubMed Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M: Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem. 2004, 279: 2712-2718.CrossRefPubMed
14.
go back to reference Ramos HC, Rumbo M, Sirard JC: Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12: 509-517. 10.1016/j.tim.2004.09.002.CrossRefPubMed Ramos HC, Rumbo M, Sirard JC: Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12: 509-517. 10.1016/j.tim.2004.09.002.CrossRefPubMed
15.
go back to reference Hybiske K, Ichikawa JK, Huang V, Lory SJ, Machen TE: Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol. 2004, 6: 49-63. 10.1046/j.1462-5822.2003.00342.x.CrossRefPubMed Hybiske K, Ichikawa JK, Huang V, Lory SJ, Machen TE: Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol. 2004, 6: 49-63. 10.1046/j.1462-5822.2003.00342.x.CrossRefPubMed
16.
go back to reference Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM: Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun. 2005, 73: 7151-7160. 10.1128/IAI.73.11.7151-7160.2005.CrossRefPubMedPubMedCentral Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM: Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun. 2005, 73: 7151-7160. 10.1128/IAI.73.11.7151-7160.2005.CrossRefPubMedPubMedCentral
17.
go back to reference Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI: Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002, 3: 354-359. 10.1038/ni777.CrossRefPubMed Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI: Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002, 3: 354-359. 10.1038/ni777.CrossRefPubMed
18.
go back to reference Luzar MA, Thomassen MJ, Montie TC: Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun. 1985, 50: 577-582.PubMedPubMedCentral Luzar MA, Thomassen MJ, Montie TC: Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun. 1985, 50: 577-582.PubMedPubMedCentral
19.
go back to reference Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S: Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci U S A. 2004, 101: 6664-6668. 10.1073/pnas.0307553101.CrossRefPubMedPubMedCentral Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S: Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci U S A. 2004, 101: 6664-6668. 10.1073/pnas.0307553101.CrossRefPubMedPubMedCentral
20.
go back to reference Sonawane A, Jyot J, During R, Ramphal R: Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun. 2006, 74: 6682-6689. 10.1128/IAI.00922-06.CrossRefPubMedPubMedCentral Sonawane A, Jyot J, During R, Ramphal R: Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun. 2006, 74: 6682-6689. 10.1128/IAI.00922-06.CrossRefPubMedPubMedCentral
21.
go back to reference López-Boado YS, Espinola M, Bahr S, Belaaouaj A: Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J Immunol. 2004, 172: 509-515. 10.4049/jimmunol.172.1.509.CrossRefPubMed López-Boado YS, Espinola M, Bahr S, Belaaouaj A: Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity. J Immunol. 2004, 172: 509-515. 10.4049/jimmunol.172.1.509.CrossRefPubMed
22.
go back to reference Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG: Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002, 184: 1140-1154. 10.1128/jb.184.4.1140-1154.2002.CrossRefPubMedPubMedCentral Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG: Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002, 184: 1140-1154. 10.1128/jb.184.4.1140-1154.2002.CrossRefPubMedPubMedCentral
23.
go back to reference Wagner VE, Iglewski BH: P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008, 35: 124-134. 10.1007/s12016-008-8079-9.CrossRefPubMed Wagner VE, Iglewski BH: P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008, 35: 124-134. 10.1007/s12016-008-8079-9.CrossRefPubMed
24.
go back to reference Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP: Gene expression in Pseudomonas aeruginosa biofilms. Nature. 2001, 413: 860-864. 10.1038/35101627.CrossRefPubMed Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP: Gene expression in Pseudomonas aeruginosa biofilms. Nature. 2001, 413: 860-864. 10.1038/35101627.CrossRefPubMed
25.
go back to reference Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jørgensen A, Molin S, Tolker-Nielsen T: Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol. 2003, 48: 1511-1524. 10.1046/j.1365-2958.2003.03525.x.CrossRefPubMed Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jørgensen A, Molin S, Tolker-Nielsen T: Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol. 2003, 48: 1511-1524. 10.1046/j.1365-2958.2003.03525.x.CrossRefPubMed
26.
go back to reference Verma A, Arora SK, Kuravi SK, Ramphal R: Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun. 2005, 73: 8237-8246. 10.1128/IAI.73.12.8237-8246.2005.CrossRefPubMedPubMedCentral Verma A, Arora SK, Kuravi SK, Ramphal R: Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun. 2005, 73: 8237-8246. 10.1128/IAI.73.12.8237-8246.2005.CrossRefPubMedPubMedCentral
27.
go back to reference Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM: Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003, 2: 29-34. 10.1016/S1569-1993(02)00141-8.CrossRefPubMed Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM: Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003, 2: 29-34. 10.1016/S1569-1993(02)00141-8.CrossRefPubMed
28.
go back to reference Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME: Effect of aerosolized recombinant human DNase on exacerbations of pulmonary symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994, 331: 637-642. 10.1056/NEJM199409083311003.CrossRefPubMed Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME: Effect of aerosolized recombinant human DNase on exacerbations of pulmonary symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994, 331: 637-642. 10.1056/NEJM199409083311003.CrossRefPubMed
29.
go back to reference Arora SK, Dasgupta N, Lory S, Ramphal R: Identification of two distinct types of flagellar cap proteins, FliD, in Pseudomonas aeruginosa. Infect Immun. 2000, 68: 1474-1479. 10.1128/IAI.68.3.1474-1479.2000.CrossRefPubMedPubMedCentral Arora SK, Dasgupta N, Lory S, Ramphal R: Identification of two distinct types of flagellar cap proteins, FliD, in Pseudomonas aeruginosa. Infect Immun. 2000, 68: 1474-1479. 10.1128/IAI.68.3.1474-1479.2000.CrossRefPubMedPubMedCentral
30.
go back to reference McIsaac SM, Stadnyk AW, Lin TJ: Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. J Leukoc Biol. 2012, 92: 977-985. 10.1189/jlb.0811410.CrossRefPubMed McIsaac SM, Stadnyk AW, Lin TJ: Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. J Leukoc Biol. 2012, 92: 977-985. 10.1189/jlb.0811410.CrossRefPubMed
31.
go back to reference Balloy V, Verma A, Kuravi S, Si-Tahar M, Chignard M, Ramphal R: The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis. 2007, 196: 289-296. 10.1086/518610.CrossRefPubMed Balloy V, Verma A, Kuravi S, Si-Tahar M, Chignard M, Ramphal R: The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis. 2007, 196: 289-296. 10.1086/518610.CrossRefPubMed
32.
go back to reference Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, Stefanowicz D, Chilvers MA, Durie PR, Corey M, Zielenski J, Dorfman R, Sandford AJ, Daley D, Turvey SE: TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. J Immunol. 2010, 185: 7731-7738. 10.4049/jimmunol.1001513.CrossRefPubMed Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, Stefanowicz D, Chilvers MA, Durie PR, Corey M, Zielenski J, Dorfman R, Sandford AJ, Daley D, Turvey SE: TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. J Immunol. 2010, 185: 7731-7738. 10.4049/jimmunol.1001513.CrossRefPubMed
33.
go back to reference Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schäfer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D: Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol. 2013, 190: 1276-1284. 10.4049/jimmunol.1202144.CrossRefPubMed Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schäfer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D: Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol. 2013, 190: 1276-1284. 10.4049/jimmunol.1202144.CrossRefPubMed
34.
go back to reference Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, Rabin HR, Surette MG: Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One. 2013, 8: e60225-10.1371/journal.pone.0060225.CrossRefPubMedPubMedCentral Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, Rabin HR, Surette MG: Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One. 2013, 8: e60225-10.1371/journal.pone.0060225.CrossRefPubMedPubMedCentral
Metadata
Title
Flagellin concentrations in expectorations from cystic fibrosis patients
Authors
Viviane Balloy
Guiti Thévenot
Thierry Bienvenu
Philippe Morand
Harriet Corvol
Annick Clement
Reuben Ramphal
Dominique Hubert
Michel Chignard
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-100

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.